A review of influenza haemagglutinin receptor binding as it relates to pandemic properties

Vaccine

Volumn 30, Issue 29, 2012, Pages 4369-4376

  Wilks, Sam ^a   de Graaf, Miranda ^a,b   Smith, Derek J ^a   Burke, David F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Haemagglutinin; Influenza virus; Pandemic; Sialic acid

Indexed keywords

HEMAGGLUTININ; SIALIC ACID; SIALIDASE;

ADAPTATION; AVIAN INFLUENZA; DISEASE TRANSMISSION; HOST RANGE; HUMAN; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; LIFE CYCLE; MORTALITY; NONHUMAN; PANDEMIC INFLUENZA; PATHOGENICITY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; UPPER RESPIRATORY TRACT INFECTION; VIRUS CAPSID; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; BIRDS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST SPECIFICITY; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS;

EID: 84861968318     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.076     Document Type: Review

References (53)

1. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Infect Dis 2006, 12(January (1)):9-14.
2. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(August (7258)):1021-1025.
3. WHO. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. 2011 22/06/2011 [cited 2011; 29/06/2011]; Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO up before 22nd June 2011, cited; Available from: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2011_06_22/en/index.html.
4. CDC. Avian Influenza A Virus Infections of Humans. 2008 23/05/2008 [cited 2011; 29/06/2011]; Information on confirmed cases of avian influenza A virus infections in humans. Available from: http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.html.
5. Wang H., Feng Z., Shu Y., Yu H., Zhou L., Zu R., et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008, 371(April (9622)):1427-1434.
6. Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Puthavathana P., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352(January (4)):333-340.
7. Kandun I.N., Wibisono H., Sedyaningsih E.R., Yusharmen Hadisoedarsuno W., Purba W., et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006, 355(November (21)):2186-2194.
8. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358(January (3)):261-273.
9. Bean W.J., Schell M., Katz J., Kawaoka Y., Naeve C., Gorman O., et al. Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol 1992, 66(February (2)):1129-1138.
10. Connor R.J., Kawaoka Y., Webster R.G., Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205(November (1)):17-23.
11. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 2000, 74(September (18)):8502-8512.
12. Matrosovich M., Gambaryan A., Klenk H. Receptor specificity of influenza viruses and its alteration during interspecies transmission. Avian Influenza 2008, Karger Publishers, (p. 134-55).
13. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56(March (1)):152-179.
14. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305(July (5682)):371-376.
15. Fouchier R.A., Smith D.J. Use of antigenic cartography in vaccine seed strain selection. Avian Dis 2010, 54(March (1 Suppl.)):220-223.
16. Potter C.W. A history of influenza. J Appl Microbiol 2001, 91(October (4)):572-579.
17. Bouvier N.M., Palese P The biology of influenza viruses. Vaccine 2008, 26(September (Suppl. 4)):D49-D53.
18. Rogers G.N., Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127(June (2)):361-373.
19. Rogers G.N., D'Souza B.L. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 1989, 173(November (1)):317-322.
20. Baum L.G., Paulson J.C. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 1990, 40:35-38.
21. Bodewes R., Kreijtz J.H., van Amerongen G., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F., et al. Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am J Pathol 2011, 179(July (1)):30-36.
22. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007, 315(February (5812)):655-659.
23. Van Hoeven N., Pappas C., Belser J.A., Maines T.R., Zeng H., Garcia-Sastre A., et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A 2009, 106(March (9)):3366-3371.
24. Matrosovich M.N., Krauss S., Webster R.G. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 2001, 281(March (2)):156-162.
25. Gambaryan A., Tuzikov A., Pazynina G., Bovin N., Balish A., Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006, 344(January (2)):432-438.
26. Carroll S.M., Higa H.H., Paulson J.C. Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem 1981, 256(August (16)):8357-8363.
27. Choppin P.W., Tamm I. Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic. Virology 1959, August (8):539-542.
28. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 1997, 71(April (4)):3357-3362.
29. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440(March (7083)):435-436.
30. Matrosovich M., Matrosovich T., Uhlendorff J., Garten W., Klenk H.D. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 2007, 361(May (2)):384-390.
31. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 2004, 101(March (13)):4620-4624.
32. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12(October (10)):1203-1207.
33. Maines T.R., Chen L.M., Van Hoeven N., Tumpey T.M., Blixt O., Belser J.A., et al. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 2011, 413(April (1)):139-147.
34. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus AD, et al. H5N1 virus attachment to lower respiratory tract. Science 2006, 312(April (5772)):399.
35. Sorrell E.M., Wan H., Araya Y., Song H., Perez D.R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A 2009, 106(May (18)):7565-7570.
36. Ayora-Talavera G., Shelton H., Scull M.A., Ren J., Jones I.M., Pickles R.J., et al. Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS One 2009, 4(11):e7836.
37. Chutinimitkul S., van Riel D., Munster V.J., van den Brand J.M., Rimmelzwaan G.F., Kuiken T., et al. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 2010, 84(July (13)):6825-6833.
38. Chandrasekaran A., Srinivasan A., Raman R., Viswanathan K., Raguram S., Tumpey T.M., et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 2008, 26(January (1)):107-113.
39. Kumari K., Gulati S., Smith D.F., Gulati U., Cummings R.D., Air G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 2007, 4:42.
40. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006, 355(February (5)):1143-1155.
41. van Riel D., den Bakker M.A., Leijten L.M., Chutinimitkul S., Munster V.J., de Wit E., et al. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol 2010, 176(April (4)):1614-1618.
42. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007, 171(October (4)):1215-1223.
43. Castrucci M.R., Donatelli I., Sidoli L., Barigazzi G., Kawaoka Y., Webster R.G. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 1993, 193(March (1)):503-506.
44. Ma W., Kahn R.E., Richt J.A. The pig as a mixing vessel for influenza viruses: Human and veterinary implications. J Mol Genet Med 2008, 3(1):158-166.
45. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459(June (7250)):1122-1125.
46. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998, 72(September (9)):7367-7373.
47. Ma W., Vincent A.L., Gramer M.R., Brockwell C.B., Lager K.M., Janke B.H., et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci U S A 2007, 104(December (52)):20949-20954.
48. Gambaryan A.S., Karasin A.I., Tuzikov A.B., Chinarev A.A., Pazynina G.V., Bovin N.V., et al. Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells. Virus Res 2005, 114(December (1-2)):15-22.
49. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353(September (13)):1374-1385.
50. Varki A. Sialic acids in human health and disease. Trends Mol Med 2008, 14(August (8)):351-360.
51. Webster R., Walter E. The world is teetering on the edge of a pandemic that could kill a large fraction of the human population. Am Scientist 2003, 2003:122-123.
52. Kuiken T., Taubenberger JK Pathology of human influenza revisited. Vaccine 2008, 26(September (Suppl. 4)):D59-D66.
53. Uyeki T.M. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009, 49(July (2)):279-290.